Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 07, 2017 05:33 ET | Source: Photocure ASA

Photocure ASA: Presentation of the fourth quarter and full year 2016 results

Photocure will present its fourth quarter and full year 2016 report on Wednesday 15 February 2017 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives...
February 03, 2017 02:00 ET | Source: Photocure ASA

Photocure Completes Enrollment in US Market expansion study of Blue Light Flexible Cystoscopy (BLFC) with Cysview ®

Oslo, Norway, February 3, 2017 Photocure ASA (OSE: PHO), announced today that it has completed enrollment in its Phase 3 study with BLFC with Cysview in patients with Non Muscle Invasive Bladder...
January 09, 2017 03:53 ET | Source: Photocure ASA

Photocure to present at investor meetings in San Francisco

Oslo, Norway, January 9, 2017Photocure ASA (OSE: PHO) management is this week conducting investor meetings in San Francisco (US) in connection with the J.P. Morgan healthcare conference. ...
December 05, 2016 02:00 ET | Source: Photocure ASA

Photocure ASA: US registry shows that Blue Light Cystoscopy (BLC) with Cysview®/Hexvix® leads to improved detection and classification of bladder cancer

Oslo, Norway, December 5, 2016 Photocure ASA (PHO-NO) announced today new data from a prospective multicenter real world study that included 338 patients, 415 BLC procedures and 1060 lesions from...
November 30, 2016 09:57 ET | Source: Photocure ASA

Photocure ASA: Share capital increase registered

Reference is made to the announcement on 24 November 2016 in respect of a capital increase of 12 481 new shares following exercise of employee share options in the company. The share capital...
November 28, 2016 02:00 ET | Source: Photocure ASA

Photocure ASA: Blue Light Cystoscopy (BLC) with Cysview®/Hexvix® decreases the risk of progression and recurrence in bladder cancer

Oslo, Norway, November 28th, 2016 Photocure ASA announced the publication of The Comparative effectiveness of fluorescence cystoscopy versus white light cystoscopy (WLC) for initial diagnosis or...
November 24, 2016 02:02 ET | Source: Photocure ASA

Photocure ASA: Update on management shareholdings and exercise of employee share

Update on management shareholdings and exercise of employee share options in Photocure ASA ("the Company"). Oslo, Norway, 24 November 20161. Participants in the Photocure's share option program...
November 21, 2016 05:32 ET | Source: Photocure ASA

Photocure ASA: Strong recommendations for Blue Light Cystoscopy with Hexvix® in new French Guidelines

Oslo, Norway, November, 21 2016: Photocure ASA (OSE:PHO) announced today that new 2016 French National Guidelines for the management of Bladder Cancer includes its Blue Light Cystoscopy (BLC) with...
November 15, 2016 01:32 ET | Source: Photocure ASA

Photocure ASA: Results for third quarter 2016

Oslo, Norway, 15 November 2016: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology, reported a revenue growth of 17 % to NOK...
November 09, 2016 07:18 ET | Source: Photocure ASA

Photocure ASA: Presentation of the third quarter 2016 results

Photocure will present its third quarter report on Tuesday 15 November 2016 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will...